MedTrace Logo

Nasal Airflow to Modulate Dyspnea in Tracheostomized Patients

NCT07308171 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-01-29

No results posted yet for this study

Summary

The hypothesis of the present study is that restoring nasal stimulation alleviates dyspnea and improves respiratory drive. The aim of this study is to compare three non-pharmacological approaches designed to restore nasal stimulation (continuous nasal airflow, nasal sprays, and facial airflow) in tracheotomized patients dependent on mechanical ventilation.

Conditions

  • Ventilated Patients

Interventions

PROCEDURE

Baseline

patient ventilated through the tracheostomy with initial ventilator settings

PROCEDURE

Installation of high flow humidified air cannula

Installation of high flow humidified air cannula with inspired oxygen fraction (FiO2) 21%

PROCEDURE

Nasal air puffs

Nasal air puffs synchronized with the inspiratory time of the ventilator

PROCEDURE

propeller fan (FAN)

Stand-alone fan at the bedside directed toward the face of the patient

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Martin Dres, MD PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2027-02-28
Completion
2027-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07308171 on ClinicalTrials.gov